Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

IQVIA HOLDINGS INC.

(IQV)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/16/2021 06/17/2021 06/18/2021 06/21/2021 06/22/2021 Date
244.23(c) 246.3(c) 239.66(c) 243.45(c) 243.98(c) Last
998 084 1 136 143 4 072 064 1 065 508 1 049 968 Volume
-1.03% +0.85% -2.70% +1.58% +0.22% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 13 426 M - -
Net income 2021 808 M - -
Net Debt 2021 9 900 M - -
P/E ratio 2021 58,7x
Yield 2021 -
Sales 2022 14 545 M - -
Net income 2022 1 021 M - -
Net Debt 2022 9 185 M - -
P/E ratio 2022 45,8x
Yield 2022 -
Capitalization 46 761 M 46 761 M -
EV / Sales 2021 4,22x
EV / Sales 2022 3,85x
Nbr of Employees 72 000
Free-Float 74,2%
More Financials
Company
IQVIA Holdings Inc., formerly Quintiles IMS Holdings, Inc., provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions,... 
More about the company
Ratings of IQVIA Holdings Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about IQVIA HOLDINGS INC.
06/16TEVA PHARMACEUTICAL INDUSTRIES  : Unit Launches Generic Version of Soolantra Cre..
MT
06/14IQVIA  : Subsidiary Expands Laboratory Operations in Scotland
MT
06/14IQVIA  : Q² Solutions Announces Significant Expansion of Laboratory Operations i..
BU
06/11IPSEN  : Finds Potential Treatment Gap Among Spasticity Patients in US
MT
06/08IQVIA  : Q2 Solutions and Tasso Collaborate to Provide Unique Solutions for Pati..
BU
06/04PRESS RELEASE : Novartis announces Tabrecta(R) -2-
DJ
06/03IQVIA  : Global Oncology Innovation Continues Despite Pandemic; Global R&D Pipel..
BU
05/26PRESS RELEASE : Marinomed Biotech AG Reports Financial Results for 1st Quarter 2..
DJ
05/20IQVIA  : CFO, Ron Bruehlman, to Speak at the William Blair Growth Stock Conferen..
BU
05/19IQVIA  : Pharma R&D Activity Surges Even Without COVID-19, Says Report from the ..
BU
05/17PRESS RELEASE : Novartis: US Supreme Court denies Sandoz petition to review bios..
DJ
05/14IQVIA  : KeyBanc Adjusts IQVIA Holdings' Price Target to $260 From $255, Keeps O..
MT
05/13MOVES-Deutsche Bank hires investment banking veteran Priyanka Verma in health..
RE
05/13Top scientists question the need for COVID-19 booster shots
RE
05/12IQVIA  : Argus Adjusts IQVIA Holdings' Price Target to $260 From $220, Keeps Buy..
MT
More news
News in other languages on IQVIA HOLDINGS INC.
06/16KOLINPHARMA  : esclusiva per distribuzione dispositivo medico Dolatrox
05/26DGAP-NEWS : Marinomed Biotech AG berichtet Finanzergebnisse für das 1. Quartal 2..
03/24L'agenda di domani
03/24J&J  : de nouvelles collaborations contre la tuberculose
03/24L'agenda della settimana
More news
Analyst Recommendations on IQVIA HOLDINGS INC.
More recommendations
Chart IQVIA HOLDINGS INC.
Duration : Period :
IQVIA Holdings Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IQVIA HOLDINGS INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 22
Last Close Price 243,98 $
Average target price 256,58 $
Spread / Average Target 5,16%
EPS Revisions
Managers and Directors
NameTitle
Ari Bousbib Chairman, President & Chief Executive Officer
Ronald Earl Bruehlman Chief Financial Officer & Executive Vice President
Karl Guenault Chief Information Officer & Senior Vice President
W. Richard Staub President-Research & Development Solutions
Kevin C. Knightly President-Technology & Commercial Solutions
Sector and Competitors
1st jan.Capitalization (M$)
IQVIA HOLDINGS INC.36.17%46 761
MODERNA, INC.111.89%83 614
LONZA GROUP AG13.26%52 103
CELLTRION, INC.-24.79%33 793
SEAGEN INC.-9.40%28 728
HANGZHOU TIGERMED CONSULTING CO., LTD14.49%24 977